Ribonucleic Acid (RNA) Sequencing Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports

 This market research is a valuable tool for leaders seeking to align their strategies with the realities and opportunities in the ribonucleic acid (rna) sequencing industry.

 

 How Large Will The Ribonucleic Acid (RNA) Sequencing Market Be By 2025?
 The ribonucleic acid (rna) sequencing market size has grown exponentially in recent years. It will grow from $3.25 billion in 2024 to $3.96 billion in 2025 at a compound annual growth rate (CAGR) of 21.8%. The growth in the historic period can be attributed to rising number of drug development activities, growing prevalence of genetic disorders and target diseases, increasing use of miniaturized portable instruments, growing use of biomarker profiling, growing demand for personalized medicine, and the increasing number of cancer patients.
 
 The ribonucleic acid (rna) sequencing market size is expected to see exponential growth in the next few years. It will grow to $8.34 billion in 2029 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to rise in demand for rapid and accurate diagnosis of disease, growing adoption of real-time polymerase chain reaction, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and demand for companion diagnostics. Major trends in the forecast period include disease detection and monitoring, drug discovery, target validation, biomarker identification, DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp
 
 What Are Key Factors Driving The Demand In The Global Ribonucleic Acid (RNA) Sequencing Market?
 An increasing focus on precision medicine is expected to propel the growth of the ribonucleic acid (RNA) sequencing market going forward. Precision medicine or personalized medicine is an innovative approach to medical treatment and prevention that considers individual variability in genes, environment, and lifestyle for each person. Personalized medicine has the potential to provide more effective treatments, advancements in genomics, increasing disease complexity, and regulatory support. RNA sequencing technologies are utilized to determine the sequence and quantify the expression levels of RNA molecules within a sample. It enables comprehensive analysis of transcriptomes and insights into gene expression patterns, alternative splicing events, and RNA modifications. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, increasing focus on precision medicine drives the ribonucleic acid (RNA) sequencing market.
 
 Comparative Analysis Of Leading Ribonucleic Acid (RNA) Sequencing Market Segments
 The ribonucleic acid (rna) sequencingmarket covered in this report is segmented — 
 
 1) By Product Type: Instruments; Reagents And Kits; Software
 2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing
 3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications
 4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
 
 Subsegments:
 1) By Instruments: Next-Generation Sequencers; Microarray Instruments; Single-Cell Rna Sequencing Instruments 
 2) By Reagents And Kits: Rna Extraction Kits; Rna Sequencing Kits; Library Preparation Kits 
 3) By Software: Data Analysis Software; Data Management Software; Bioinformatics Software
 
 What Are The Upcoming Trends Of Ribonucleic Acid (RNA) Sequencing Market In The Globe?
 Major companies operating in the ribonucleic acid (RNA) sequencing market focus on RNA next-generation sequencing assay to improve patient care through data-driven insights and precision medicine. RNA next-generation sequencing assay is a next-generation exome sequencing platform that leverages advanced genomic sequencing technologies to analyze a patient’s entire exome. For instance, in June 2023, Tempus, a US-based precision medicine technology company, unveiled its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, designed for solid tumors, offers a comprehensive analysis of the entire transcriptome, highlighting clinically significant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This offering caters to physicians with a specific interest in RNA fusions or altered splicing and providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis of their existing samples.
 
 Who Are The Prominent Players In The Ribonucleic Acid (RNA) Sequencing Business?
 Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Genomics Inc., Natera Inc., Myriad Genetics Inc., BGI Genomics Co Ltd., Takara Bio Inc., Cepheid, NeoGenomics Laboratories Inc., Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., Standard BioTools Inc., Ambry Genetics Corporation, Biocartis SA, CD Genomics 
 
 View the full ribonucleic acid (rna) sequencing market report here:
 https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report
 
 Which Region Is Expected To Lead The Ribonucleic Acid (RNA) Sequencing Market By 2025?
 North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company